These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11572178)

  • 21. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
    Papadopoulos DP; Papademetriou V
    J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuretics for cardiovascular prevention in the elderly.
    Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
    Domanski M; Antman EM; McKinlay S; Varshavsky S; Platonov P; Assmann SF; Norman J
    Control Clin Trials; 2004 Dec; 25(6):553-62. PubMed ID: 15588742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revival of nifedipine, a dihydropyridine-based calcium blocker.
    Yamagishi S; Nakamura K
    Med Hypotheses; 2007; 68(3):565-7. PubMed ID: 17011717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.
    Bangalore S; Messerli FH
    Int J Clin Pract; 2006 Oct; 60(10):1281-6. PubMed ID: 16942591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medication of the month. Adalat Oros 60 mg].
    Kulbertus H
    Rev Med Liege; 2004 Mar; 59(3):158-61. PubMed ID: 15139404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
    de Leeuw PW; Ruilope LM; Palmer CR; Brown MJ; Castaigne A; Mancia G; Rosenthal T; Wagener G
    Arch Intern Med; 2004 Dec 13-27; 164(22):2459-64. PubMed ID: 15596636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

  • 32. First-line treatment for hypertension.
    Jackson PR; Ramsay LE; ;
    Eur Heart J; 2002 Feb; 23(3):179-82. PubMed ID: 11792127
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials.
    Fournier A; Messerli FH; Achard JM; Fernandez L
    J Am Coll Cardiol; 2004 Apr; 43(8):1343-7. PubMed ID: 15093864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marketing ALLHAT.
    Opie L
    Lancet; 2004 Jan; 363(9403):169-70. PubMed ID: 14726183
    [No Abstract]   [Full Text] [Related]  

  • 36. Traveling medicine shows: a modern update?
    Carroll-Johnson RM
    Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of short acting calcium channel blockers.
    Hassall JJ
    N Z Med J; 1996 Jan; 109(1014):18. PubMed ID: 8628532
    [No Abstract]   [Full Text] [Related]  

  • 38. Advertising standards.
    Drug Ther Bull; 2013 Jul; 51(7):73. PubMed ID: 23842632
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Prospective reinfaction outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT).
    Goodman S; Langer A
    Can J Cardiol; 1997 Jul; 13(7):693, 696. PubMed ID: 9251584
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence-based advertising?
    Replogle WH
    J Am Board Fam Pract; 2001; 14(5):399. PubMed ID: 11572549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.